InvestorsHub Logo
Followers 5
Posts 435
Boards Moderated 0
Alias Born 04/05/2012

Re: buckiii2 post# 15708

Friday, 08/01/2014 1:08:35 PM

Friday, August 01, 2014 1:08:35 PM

Post# of 20775
buckiii2...if you go back to the June 20 2013 press release you'll see they say that orphan drug status wouldn't be applied for until after Phase 2 proof of concept was completed and reviewed...that is years away so that isn't anytime soon. I don't think they get any milestone from a completion of phase 1b or start of phase2, but I could be wrong. One thing is for sure, if Intellect doesn't get bought out or get a partnership soon then this stock is going to plummet. That 1.2 million won't last very long. The 6 million they received at the end of 2011 from Viopharma didn't last very long so 1.2 is only going to get us so far. GLTA

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.